Interstitial lung diseases (ILDs) are a large group of pulmonary disorders characterized
histologically by the cardinal involvement of the pulmonary interstitium. The prototype of …

Interstitial lung disease (ILD) encompasses a diverse group of parenchymal lung diseases
characterized by varying degrees of inflammation and/or fibrosis. Patients with ILD …

Patients with acute exacerbation of lung fibrosis with usual interstitial pneumonia (EUIP)
pattern are at increased risk for ventilator-induced lung injury (VILI) and mortality when …

Background Interstitial lung disease (ILD) is a group of restrictive pulmonary diseases
associated with diffuse interstitial and parenchymal inflammation. Patients can present to the …

With the advent of new therapies and improvements in supportive care, survivorship in
patients with interstitial lung disease (ILD) is increasing. However, this increase in number of …

Background and Objectives: Acute exacerbation of idiopathic pulmonary fibrosis (IPF-AE)
often results in severe respiratory distress requiring treatment in the intensive care unit and …

Interstitial lung diseases (ILDs) are a heterogeneous group of chronic lung diseases caused
by several potential etiologies but for many, the cause of a given ILD remains unknown …

Acute exacerbation of interstitial ling disease (AE-ILD) denotes a rapid deterioration of
respiratory function often leading to ICU admission due to severe hypoxemia. Definitions …

Background and Objectives: Acute exacerbation of idiopathic pulmonary fibrosis (IPF-AE)
often results in severe respiratory distress requiring treatment in the intensive care unit and …